Many Canadians may be unaware that Benadryl, a common allergy medication, is no longer recommended as a first-choice treatment for allergies, according to health experts. The shift in guidelines reflects growing concerns over the drug's side effects and the availability of safer, more effective alternatives.
Why Benadryl Is No Longer Preferred
Benadryl, known generically as diphenhydramine, is a first-generation antihistamine. While effective at relieving allergy symptoms, it can cause significant drowsiness and impair cognitive function. Newer second-generation antihistamines, such as cetirizine, loratadine, and fexofenadine, are less sedating and have fewer side effects.
Dr. Elinor Simons, an allergist, emphasizes that patients should be aware of these updated recommendations. "Many people still reach for Benadryl out of habit, but there are better options available that provide relief without the same level of drowsiness," she says.
Expert Advice for Allergy Season
As allergy season approaches, experts advise Canadians to consult with healthcare professionals about the most appropriate medications for their symptoms. Non-sedating antihistamines are now the first line of defense for seasonal allergies, along with nasal corticosteroids and eye drops.
Dr. Simons recommends starting medication before symptoms peak and considering environmental controls like keeping windows closed during high pollen counts. "Preparation is key to managing allergies effectively," she adds.
Public Awareness Gap
Despite the updated guidelines, a survey suggests that a significant portion of Canadians still believe Benadryl is the best option. Health Canada and medical associations are working to educate the public about the change. The message is clear: for most people, newer antihistamines are safer and equally effective.
Patients currently using Benadryl are encouraged to speak with their pharmacist or doctor about switching to a more suitable alternative. This is particularly important for older adults, children, and those with certain medical conditions who may be more susceptible to side effects.
